#CTSM Transcript
Healthcare social media transcript of the #CTSM hashtag.
– ().
See #CTSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | Cure Forward @CureForward Hello everybody! Welcome to #ClinicalTrials Social Media, aka, #ctsm |
 | Cancer for Christmas @CancerForXmas Starting NOW! #Science nerds tune in to #ctsm to talk #clinicaltrials + #cancer w/ @thecancergeek + @CureForward https://t.co/PilH2iPDyq https://t.co/VNlthibz7I |
 | Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey Starting NOW! #Science nerds tune in to #ctsm to talk #clinicaltrials + #cancer w/ @thecancergeek + @CureForward https://t.co/oak2worEpX https://t.co/2Vyiq08Bpy |
| Cure Forward @CureForward Tonight we’re talking #breastcancer #clinicaltrials with our guest @thecancergeek - researcher, #clinicaltrials coordinator, and geek! #ctsm |
 | Angela Alexander PhD @thecancergeek Hi I’m Angela. Cancer biologist and geek. Basic science PhD in cancer cell biology, then breast cancer research as a postdoc #ctsm |
 | Inspire @InspireIsHealth RT @CancerForXmas: Starting NOW! #Science nerds tune in to #ctsm to talk #clinicaltrials + #cancer w/ @thecancergeek + @CureForward https://t.co/PilH2iPDyq https://t.co/VNlthibz7I |
 | @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Starting NOW #ctsm TweetChat with @thecancergeek, Join in! #MMSM |
| Cure Forward @CureForward @thecancergeek Hi Angela! We are thrilled to have you as our featured guest tonight! #ctsm |
 | Jamie Holloway, PhD @jamienholloway Oh y'all. Still in the 7:15 meeting. Gonna be tweeting light tonight. #CTSM |
| Cure Forward @CureForward Here is background on tonight's chat - a great interview with @thecancergeek, and a preview of the topics: https://t.co/o84mQ0imE1 #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey Greetings, Earthlings! Casey Q here, @CureForward #PMA and breast #cancer survivor. #OpenScience #OpenData evangelist. #ctsm |
| Angela Alexander PhD @thecancergeek @CureForward honored to be asked to participate. :) #ctsm |
| Cure Forward @CureForward @jamienholloway Hey Jamie! We will see you when you're ready! #ctsm |
| Cure Forward @CureForward @MightyCasey Hi there Casey! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @CureForward honored to be asked to participate. :) #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey I'm on the tail end of a long writing day, with an early (5:30am ET) reveille tomorrow. May run outta gas before 10pm ET! #ctsm |
| Cure Forward @CureForward @thecancergeek :-) #ctsm |
| Cure Forward @CureForward For information about tweetchats, please see this page: https://t.co/MtSkdviOsg #ctsm |
| Cure Forward @CureForward RT @MightyCasey: I'm on the tail end of a long writing day, with an early (5:30am ET) reveille tomorrow. May run outta gas before 10pm ET! #ctsm |
| Inspire @InspireIsHealth RT @CureForward: Here is background on tonight's chat - a great interview with @thecancergeek, and a preview of the topics: Here is background on tonight's chat - a great interview with @thecancergeek, and a preview of the topics: https://t.co/o84mQ0imE1 #ctsm |
 | Dr. Kelly Shanahan @stage4kelly Hi all! Kelly, former ob-gyn, current MBCer, with @METUPorg .looking forward to learning from @thecancergeek! #ctsm |
 | Dave Bjork @bjork5 @MightyCasey @CureForward You rock Casey! #ctsm #PrecisionMedicine |
| Cure Forward @CureForward @MightyCasey Thank you for joining us, given your tight schedule! #ctsm |
| Cure Forward @CureForward Please take a moment to say hello and introduce yourselves and we will get started soon. #ctsm |
| Cure Forward @CureForward RT @stage4kelly: Hi all! Kelly, former ob-gyn, current MBCer, with @METUPorg .looking forward to learning from @thecancergeek! #ctsm |
| Cure Forward @CureForward @stage4kelly @METUPorg @thecancergeek Hi Kelly! Great to see you! #ctsm |
| Cure Forward @CureForward Yes she does! And so do you! RT @bjork5: @MightyCasey @CureForward You rock Casey! #ctsm #PrecisionMedicine |
 | CancerGeek @CancerGeek RT @MightyCasey: Starting NOW! #Science nerds tune in to #ctsm to talk #clinicaltrials + #cancer w/ @thecancergeek + @CureForward https://t.co/oak2worEpX https://t.co/2Vyiq08Bpy |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: For information about tweetchats, please see this page: For information about tweetchats, please see this page: https://t.co/MtSkdviOsg #ctsm |
| Cure Forward @CureForward If you are lurking/reading/listening tonight, please say hi so we know you’re here! #ctsm |
| Inspire @InspireIsHealth Hello to #ctsm, John Novack here from healthcare social network Inspire. |
| Cure Forward @CureForward At @cureforward we're working to help patients get their data, find treatment options & clinical trials https://t.co/FzqnJn31nO #ctsm |
| Cure Forward @CureForward @teaminspire Hi John! Thanks for joining us tonight! #ctsm |
| Cure Forward @CureForward RT @teaminspire: Hello to #ctsm, John Novack here from healthcare social network Inspire. |
| Cure Forward @CureForward At @cureforward we ask why can’t we use tech to transform how people access services that matter most? https://t.co/FzqnJn31nO #ctsm |
| Cure Forward @CureForward @FrankIngari reminds us: cancer txs "can only reach patients after undergoing the Clinical Trial process" https://t.co/5jJvGF3Oy0 #ctsm |
| Cure Forward @CureForward Great read from @FrankIngari on #clinicaltrials. Why we do what we do at @cureforward. https://t.co/5jJvGF3Oy0 #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher My name is Cindy DX w/ #Myeloma in 2008 Currently in a VGPR on Maintenace Therapy & a @CureForward #PrecisionMedicine Advocate #MMSM #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: My name is Cindy DX w/ #Myeloma in 2008 Currently in a VGPR on Maintenace Therapy & a @CureForward #PrecisionMedicine Advocate #MMSM #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: Great read from @FrankIngari on #clinicaltrials. Why we do what we do at @cureforward. https://t.co/5jJvGF3Oy0 #ctsm |
| Cure Forward @CureForward @MyelomaTeacher Hi Cindy! Great to see you tonight! #ctsm |
| Dave Bjork @bjork5 @CureForward Hey Dave B here in Boston. Lung cancer survivor, #PrecisionMedicine advocate, & #research evangelist #ctsm |
| Cure Forward @CureForward Hi & shoutout to our pioneering #precisionmedicine advocacy team! More info on these great advocates here: https://t.co/HCTueyh47e #ctsm |
| Cure Forward @CureForward RT @bjork5: @CureForward Hey Dave B here in Boston. Lung cancer survivor, #PrecisionMedicine advocate, & #research evangelist #ctsm |
| Cure Forward @CureForward @bjork5 Howdy, Dave! Thank you for joining our chat tonight! #ctsm |
 | Helen Harvey @helenha00779279 Hello from Helen in PA. Diagnosed with IBC earlier this year. #ctsm |
| Cure Forward @CureForward FYI our #PrecisionMedicine #Advocates are: @CBlotner_ @bjork5 @MightyCasey @MyelomaTeacher @jamienholloway @stales & @itsthebunk #ctsm |
| Dave Bjork @bjork5 @teaminspire Hey John! #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: FYI our #PrecisionMedicine #Advocates are: FYI our #PrecisionMedicine #Advocates are: @CBlotner_ @bjork5 @MightyCasey @MyelomaTeacher @jamienholloway @stales & @itsthebunk #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey @CancerGeek @thecancergeek @CureForward If you're up/about, join #ctsm chat!! |
| Angela Alexander PhD @thecancergeek I'm glad to see both friendly peeps I know from other chats and new people joining as well. #ctsm |
 | Alicia C. Staley @stales RT @CureForward: FYI our #PrecisionMedicine #Advocates are: FYI our #PrecisionMedicine #Advocates are: @CBlotner_ @bjork5 @MightyCasey @MyelomaTeacher @jamienholloway @stales & @itsthebunk #ctsm |
| Cure Forward @CureForward @HelenHa00779279 Hi Helen, welcome to the chat. We are sorry to hear about your diagnosis, but glad you are joining us tonight :) #ctsm |
| CancerGeek @CancerGeek RT @MightyCasey: @CancerGeek @thecancergeek @CureForward If you're up/about, join #ctsm chat!! |
| Cure Forward @CureForward RT @thecancergeek: I'm glad to see both friendly peeps I know from other chats and new people joining as well. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey @HelenHa00779279 Greetings, Helen! Welcome! #ctsm |
| Cure Forward @CureForward RT @MightyCasey: @HelenHa00779279 Greetings, Helen! Welcome! #ctsm |
| Angela Alexander PhD @thecancergeek @HelenHa00779279 Glad you could join us. I don't think I have you on my IBC list. Must fix that later! #ctsm |
| Cure Forward @CureForward Special shoutout to our #PrecisionMedicine #Advocate @itsthebunk who’s moderating tonight’s chat! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @HelenHa00779279 Glad you could join us. I don't think I have you on my IBC list. Must fix that later! #ctsm |
| Dave Bjork @bjork5 @HelenHa00779279 Welcome Helen! We're all in this together #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey @teaminspire ¡Hola, Juan! ¿Qué tal? #ctsm |
| Cure Forward @CureForward We'll do a few more minutes of introductions and then we will get started. #ctsm |
| Cure Forward @CureForward RT @bjork5: @HelenHa00779279 Welcome Helen! We're all in this together #ctsm |
| Cure Forward @CureForward RT @MightyCasey: @teaminspire ¡Hola, Juan! ¿Qué tal? #ctsm |
 | Kelly's Heroes @1KellysHeroes Hi from NJ. We're a grassroots 501c3 raising awareness & $ for pancreatic cancer research, inspired by trial participant Steve Kelly #ctsm |
| Cure Forward @CureForward RT @1KellysHeroes: Hi from NJ. We're a grassroots 501c3 raising awareness & $ for pancreatic cancer research, inspired by trial participant Steve Kelly #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher #MMSM Peeps please join in! #Myeloma #ClinicalTrials #ctsm |
| Cure Forward @CureForward @1KellysHeroes Hi there! Welcome to the chat! We are glad you are joining us! #ctsm |
| Cure Forward @CureForward Yes, and #BCSM and #AMSM peeps too! RT @MyelomaTeacher: #MMSM Peeps please join in! #Myeloma #ClinicalTrials #ctsm |
 | What Is Mesothelioma @mesotheliomacur RT https://t.co/zFOpzXVoxN Starting NOW! #Science nerds tune in to #ctsm to talk #clinicaltrials + #cancer w/ @th… https://t.co/hWo1yehVHT |
| Cure Forward @CureForward Stand by for T1 which will be up soon... meanwhile, if you haven't introduced yourself, please do! We are a friendly bunch! #ctsm |
| What Is Mesothelioma @mesotheliomacur RT https://t.co/I9caa6hZ5u Starting NOW! #Science nerds tune in to #ctsm to talk #clinicaltrials + #cancer w/ @th… https://t.co/SWEIZ0DDrK |
| Cure Forward @CureForward T1. @thecancergeek, Cancer Researcher & #ClinicalTrials Coordinator at @MDAndersonNews will tell us her story in a few tweets. #ctsm |
 | Vanessa L. Merker, PhD @vlmerker Hi all! Vanessa here, PhD candidate and clinical research coordinator for neurofibromatosis trials at Mass General Hospital in Boston #CTSM |
| Cure Forward @CureForward RT @vlmerker: Hi all! Vanessa here, PhD candidate and clinical research coordinator for neurofibromatosis trials at Mass General Hospital in Boston #CTSM |
| Cure Forward @CureForward @vlmerker Hello Vanessa! Thank you for joining us tonight! #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey @1KellysHeroes Welcome!! Pancreatic #cancer is a scary monster, all who fight it are very special peeps. #respect #ctsm |
| Angela Alexander PhD @thecancergeek T1. This year I have recently transitioned into Clinical Studies Coordinator role @MDAndersonNews IBC Program @InflammatoryBCa #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey @vlmerker Hi!!! Thanks for joining - look forward to hearing what you're discovering! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. This year I have recently transitioned into Clinical Studies Coordinator role @MDAndersonNews IBC Program @InflammatoryBCa #ctsm |
| Angela Alexander PhD @thecancergeek T1. My research focus in breast cancer has been #inflammatorybreastcancer and #TNBC, but general knowledge about all subtypes. #ctsm #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1. My research focus in breast cancer has been #inflammatorybreastcancer and #TNBC, but general knowledge about all subtypes. #ctsm #ctsm |
| Angela Alexander PhD @thecancergeek T1. However, journal reading & BC conferences keep me updated on ER+ & HER2+ biology too. IBC has large HER2+ population (40%) #ctsm |
| Cure Forward @CureForward ICYMI @thecancergeek is a cancer scientist and #clinicaltrials coordinator at @MDAndersonNews https://t.co/o84mQ0imE1 #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. My research focus in breast cancer has been #inflammatorybreastcancer and #TNBC, but general knowledge about all subtypes. #ctsm #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: ICYMI @thecancergeek is a cancer scientist and #clinicaltrials coordinator at @MDAndersonNews https://t.co/o84mQ0imE1 #ctsm |
| Angela Alexander PhD @thecancergeek T1. I’ve learned a lot from volunteering with the IBC Network Foundation (@TalkIBC), and twitter chats such as #bcsm and others. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. I’ve learned a lot from volunteering with the IBC Network Foundation (@TalkIBC), and twitter chats such as #bcsm and others. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1. I’ve learned a lot from volunteering with the IBC Network Foundation (@TalkIBC), and twitter chats such as #bcsm and others. #ctsm |
| Cure Forward @CureForward @thecancergeek @TalkIBC And we know for a fact that so many have learned so much from you! #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @CureForward: ICYMI @thecancergeek is a cancer scientist and #clinicaltrials coordinator at @MDAndersonNews https://t.co/o84mQ0imE1 #ctsm |
| Angela Alexander PhD @thecancergeek T1. I also learned a lot by spending way too many hours searching & reading on https://t.co/hdShSC5471 while helping pts find trials #ctsm |
| Alicia C. Staley @stales Hi everyone! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. I also learned a lot by spending way too many hours searching & reading on https://t.co/hdShSC5471 while helping pts find trials #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @thecancergeek: T1. I also learned a lot by spending way too many hours searching & reading on https://t.co/hdShSC5471 while helping pts find trials #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey HAIIIIII !!! RT @stales: Hi everyone! #ctsm |
| Cure Forward @CureForward @stales Hi there! #ctsm |
| Angela Alexander PhD @thecancergeek T1. My interest in improving clinical trial knowledge & enrollment led me to develop mobile app for IBC pts to learn more about trials #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. My interest in improving clinical trial knowledge & enrollment led me to develop mobile app for IBC pts to learn more about trials #ctsm |
| Angela Alexander PhD @thecancergeek T1. About the app -> https://t.co/sOULYtJ5Jj. Available for Apple https://t.co/cIGV4OJgsW and Android phones https://t.co/vAudHRA3HJ #ctsm |
 | The IBC Network Foundation @TalkIBC RT @thecancergeek: T1. About the app -> https://t.co/sOULYtJ5Jj. Available for Apple https://t.co/cIGV4OJgsW and Android phones https://t.co/vAudHRA3HJ #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @thecancergeek: T1. About the app -> https://t.co/sOULYtJ5Jj. Available for Apple https://t.co/cIGV4OJgsW and Android phones https://t.co/vAudHRA3HJ #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1. About the app -> https://t.co/sOULYtJ5Jj. Available for Apple https://t.co/cIGV4OJgsW and Android phones https://t.co/vAudHRA3HJ #ctsm |
| Angela Alexander PhD @thecancergeek T1. My academic work -> https://t.co/2j82jZeGS4. Other writing - my blog —> https://t.co/yQwdGsr9Rx (updates needed to both though) #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1. My interest in improving clinical trial knowledge & enrollment led me to develop mobile app for IBC pts to learn more about trials #ctsm |
| Cure Forward @CureForward @thecancergeek is a rockstar! To learn more about her, please see this https://t.co/o84mQ0imE1 & her blog: https://t.co/Uff2gOHfeT #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. About the app -> https://t.co/sOULYtJ5Jj. Available for Apple https://t.co/cIGV4OJgsW and Android phones https://t.co/vAudHRA3HJ #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1. My academic work -> https://t.co/2j82jZeGS4. Other writing - my blog —> https://t.co/yQwdGsr9Rx (updates needed to both though) #ctsm |
 | Cancer Research News @CancerNewsApp RT @thecancergeek: Hi I’m Angela. Cancer biologist and geek. Basic science PhD in cancer cell biology, then breast cancer research as a postdoc #ctsm |
| Inspire @InspireIsHealth RT @thecancergeek: T1. My academic work -> https://t.co/2j82jZeGS4. Other writing - my blog —> https://t.co/yQwdGsr9Rx (updates needed to both though) #ctsm |
| Cure Forward @CureForward T1a: What is a Cancer Researcher? #ctsm |
| Angela Alexander PhD @thecancergeek T1a. Cancer research takes many forms. Some research is lab based, some clinical & others are office based (computer work). All needed #ctsm |
| Angela Alexander PhD @thecancergeek T1a. I worked in a lab for 12yrs total, hands on using preclinical models (cells & little bit of mouse work). Now clinic & office #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1a. Cancer research takes many forms. Some research is lab based, some clinical & others are office based (computer work). All needed #ctsm |
| Angela Alexander PhD @thecancergeek T1a. This training set me up well for my current position as Clinical Studies Coordinator. Mix of science, logistics and patient-care. #ctsm |
| Angela Alexander PhD @thecancergeek T1a. Since the title’s so long, lets use CSC as the short term for clinical studies coordinator/trials coordinators (same role) #ctsm |
| Cure Forward @CureForward T1a. Feel free to chime in folks, if you'd like to share what you know or what you think you know about cancer researchers! #ctsm |
| Dr. Kelly Shanahan @stage4kelly @thecancergeek was so generous with her knowledge at #SABCS16. @METUPorg really appreciates how much time she spent with us! https://t.co/HVbTVWY33L |
| Cure Forward @CureForward RT @thecancergeek: T1a. I worked in a lab for 12yrs total, hands on using preclinical models (cells & little bit of mouse work). Now clinic & office #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1a. This training set me up well for my current position as Clinical Studies Coordinator. Mix of science, logistics and patient-care. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1a. Since the title’s so long, lets use CSC as the short term for clinical studies coordinator/trials coordinators (same role) #ctsm |
| Cure Forward @CureForward @thecancergeek Great idea! Thank you! #ctsm |
| Angela Alexander PhD @thecancergeek Curious what y'all wish you knew about cancer researchers? #ctsm |
| Cure Forward @CureForward RT @thecancergeek: Curious what y'all wish you knew about cancer researchers? #ctsm |
| Alicia C. Staley @stales RT @CureForward T1a: What is a Cancer Researcher? #ctsm |
| Alicia C. Staley @stales cool RT @thecancergeek T1a. Cancer research takes many forms. Some research is lab based, some clinical & others are office based #ctsm |
| Cure Forward @CureForward @thecancergeek We know our PMA @bjork5 is a #cancer research evangelist - would you care to chime in, Dave?! #ctsm |
| Dave Bjork @bjork5 @CureForward I've toured many cancer research labs. So inspiring! #ctsm #PrecisionMedicine |
| Alicia C. Staley @stales anyone? #BCSM RT @thecancergeek Curious what y'all wish you knew about cancer researchers? #ctsm |
| Cure Forward @CureForward RT @bjork5: @CureForward I've toured many cancer research labs. So inspiring! #ctsm #PrecisionMedicine |
| Cure Forward @CureForward RT @stales: anyone? #BCSM RT @thecancergeek Curious what y'all wish you knew about cancer researchers? #ctsm |
| Dr. Kelly Shanahan @stage4kelly T1a. Many community oncs don't have a CSC. Why can't pharma/academia/govt fund regional CSCs that pts can access via telemedicine? #ctsm |
| Cure Forward @CureForward Let's launch T1b: T1b: What does a Clinical Trial Coordinator do? #ctsm |
| Angela Alexander PhD @thecancergeek @TalkIBC spent the day with me in lab several years ago. Any comments Terry??? #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey @thecancergeek What I wish for = clearer public info/literacy-building on time it takes for #cancer science to become treatment #ctsm |
| Cure Forward @CureForward RT @stage4kelly: T1a. Many community oncs don't have a CSC. Why can't pharma/academia/govt fund regional CSCs that pts can access via telemedicine? #ctsm |
| Angela Alexander PhD @thecancergeek RT @MightyCasey: @thecancergeek What I wish for = clearer public info/literacy-building on time it takes for #cancer science to become treatment #ctsm |
| Cure Forward @CureForward @stage4kelly Great idea, Kelly - we will be sharing ideas later in the chat!! Save it for then (i.e., repost it!) #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @TalkIBC spent the day with me in lab several years ago. Any comments Terry??? #ctsm |
| Cure Forward @CureForward RT @MightyCasey: @thecancergeek What I wish for = clearer public info/literacy-building on time it takes for #cancer science to become treatment #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher I also wish that cancer researchers publish lay man abstracts #ctsm |
| Dave Bjork @bjork5 @thecancergeek I know many! And they are passionate about their work! #ctsm @CureForward #commitment |
| Cure Forward @CureForward @adamhayden Hi Adam! Thank you for joining us tonight! #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Cure Forward @CureForward RT @bjork5: @thecancergeek I know many! And they are passionate about their work! #ctsm @CureForward #commitment |
| Dr. Kelly Shanahan @stage4kelly T1. How can there be better collaboration with bench scientists and patients? #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @stage4kelly: T1. How can there be better collaboration with bench scientists and patients? #ctsm |
| Angela Alexander PhD @thecancergeek T1b. What do I do as a CSC? Pre-trial work: Find/screen patients for trials, check eligibility, get insurance approval #ctsm |
| Cure Forward @CureForward @MyelomaTeacher Please remember to use the #CTSM tag!! |
| Angela Alexander PhD @thecancergeek T1b. During trial - manage schedules, communicate w/ pts & attending onc’s, solve problems, gather pt info & document in med record. #ctsm |
| Cure Forward @CureForward @TalkIBC Terry! Please remember to tag your tweets with #ctsm so all can see! |
| Angela Alexander PhD @thecancergeek T1b. During trial - also collect/arrange collection of samples (blood and tissue) as needed for the correlative studies #ctsm |
| Angela Alexander PhD @thecancergeek T1b. After trial - follow up w/ pts to record outcomes & toxicity. Help with publications & reports to sponsors & FDA (if applicable) #ctsm |
| Cure Forward @CureForward #CTSM https://t.co/V2hLOS15Ef |
| Dave Bjork @bjork5 @CureForward @thecancergeek Oh yeah, brilliant people doing amazing work in labs across the country. And training the next generation of young researchers! #ctsm |
| Angela Alexander PhD @thecancergeek T1b. Other work incl meetings, keeping up with ongoing science as published in the literature & general drug approvals #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1b. During trial - manage schedules, communicate w/ pts & attending onc’s, solve problems, gather pt info & document in med record. #ctsm |
| Dr. Kelly Shanahan @stage4kelly @MyelomaTeacher I wish journals made articles accessible to patients (i.e. no paywall) #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1b. During trial - also collect/arrange collection of samples (blood and tissue) as needed for the correlative studies #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1b. After trial - follow up w/ pts to record outcomes & toxicity. Help with publications & reports to sponsors & FDA (if applicable) #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1b. Other work incl meetings, keeping up with ongoing science as published in the literature & general drug approvals #ctsm |
| Angela Alexander PhD @thecancergeek T1b. CSCs often act as liaisons between pts, oncologists, and regulatory bodies monitoring trial procedures. #ctsm |
| Inspire @InspireIsHealth RT @stage4kelly: T1. How can there be better collaboration with bench scientists and patients? #ctsm |
| Cure Forward @CureForward We are getting a an awesome overview from @thecancergeek on #clinicaltrials behind the scenes #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @stage4kelly Me too! #CTSM |
| Cure Forward @CureForward @zmadak Hi Zeynep! Welcome, cancer researcher! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T1b. CSCs often act as liaisons between pts, oncologists, and regulatory bodies monitoring trial procedures. #ctsm |
| Cure Forward @CureForward RT @stage4kelly: @MyelomaTeacher I wish journals made articles accessible to patients (i.e. no paywall) #ctsm |
| Angela Alexander PhD @thecancergeek @stage4kelly Re collaboration: Advocates being visible to the faculty running the labs. Faculty also responsible to reach out IMO #ctsm |
| Cure Forward @CureForward To learn more about @thecancergeek, please see https://t.co/o84mQ0imE1 #ctsm |
 | Hamza Khan @HamzaSKhan_ T1b. Work with the Clinical Research Associate to ensure data collected during the course of the trial is of the highest integrity. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey A-F***ING-MEN, baby >>> RT @stage4kelly: @MyelomaTeacher I wish journals made articles accessible to patients (i.e. no paywall) #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @stage4kelly Re collaboration: @stage4kelly Re collaboration: Advocates being visible to the faculty running the labs. Faculty also responsible to reach out IMO #ctsm |
| Cure Forward @CureForward RT @CRAExpert: T1b. Work with the Clinical Research Associate to ensure data collected during the course of the trial is of the highest integrity. #ctsm |
| Dave Bjork @bjork5 @stage4kelly T1: Reach out to a nonprofit and ask to be connected to a researcher. There are many out there who like meeting patients! #ctsm |
| Angela Alexander PhD @thecancergeek @CRAExpert we work with data coordinators to make sure this happens as well #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T1b. CSCs often act as liaisons between pts, oncologists, and regulatory bodies monitoring trial procedures. #ctsm |
| Cure Forward @CureForward @CRAExpert Hi there Hamza! Welcome to tonight's chat! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @CRAExpert we work with data coordinators to make sure this happens as well #ctsm |
| Cure Forward @CureForward RT @bjork5: @stage4kelly T1: @stage4kelly T1: Reach out to a nonprofit and ask to be connected to a researcher. There are many out there who like meeting patients! #ctsm |
| Cure Forward @CureForward T2. The Complex Landscape Of Breast Cancer, #BreastCancer #ClinicalTrials, And #PrecisionMedicine #ctsm |
| The IBC Network Foundation @TalkIBC @CureForward opps. loved being there. Learned abt yr work and I was a real person to the other researcher. not a stat. #ctsm |
| Angela Alexander PhD @thecancergeek T2. Breast cancer is not just 1 disease. Many subtypes w/ different underlying biology. ER, PR & HER2 biomarkers critical @ diagnosis #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @bjork5: @stage4kelly T1: @stage4kelly T1: Reach out to a nonprofit and ask to be connected to a researcher. There are many out there who like meeting patients! #ctsm |
| Vanessa L. Merker, PhD @vlmerker @MyelomaTeacher I agree! I'm sending out lay abstracts summarizing our research findings to all the patients I interview for my dissertation #ctsm |
| Angela Alexander PhD @thecancergeek T2. Clinically divide into “ER+” (also HER2-), ER+ and HER2+, HER2+ only and TNBC. Defines treatment options & expected outcomes #ctsm |
| Kelly's Heroes @1KellysHeroes @bjork5 @CureForward @thecancergeek Was honored to share my husband's story w/ researchers who developed immunotherapy drug used in his trial. Brilliant & dedicated! #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. Clinically divide into “ER+” (also HER2-), ER+ and HER2+, HER2+ only and TNBC. Defines treatment options & expected outcomes #ctsm |
| Helen Harvey @helenha00779279 RT @thecancergeek: T2. Breast cancer is not just 1 disease. Many subtypes w/ different underlying biology. ER, PR & HER2 biomarkers critical @ diagnosis #ctsm |
| Angela Alexander PhD @thecancergeek T2. ER/PR/HER2 status can change throughout course of disease e.g. change btwn primary & mets, & btwn mets. https://t.co/W1GeXBD49j #ctsm |
| Cure Forward @CureForward T2 Will surely be of great interest to our friends in the #bcsm and #amsm communities. Please join in with comments and questions! #ctsm |
| Cure Forward @CureForward RT @bjork5: @CureForward @thecancergeek Oh yeah, brilliant people doing amazing work in labs across the country. And training the next generation of young researchers! #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @CureForward: To learn more about @thecancergeek, please see https://t.co/o84mQ0imE1 #ctsm |
| Hamza Khan @HamzaSKhan_ RT @thecancergeek: T2. Breast cancer is not just 1 disease. Many subtypes w/ different underlying biology. ER, PR & HER2 biomarkers critical @ diagnosis #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Myeloma is divided into 7 subgroups based on genetic signatures. Cancer is complex! #ctsm |
| Cure Forward @CureForward RT @1KellysHeroes: @bjork5 @CureForward @thecancergeek Was honored to share my husband's story w/ researchers who developed immunotherapy drug used in his trial. Brilliant & dedicated! #ctsm |
| Angela Alexander PhD @thecancergeek Please ask if I use any terminology and forget to define it. I forget sometimes. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @MyelomaTeacher: Myeloma is divided into 7 subgroups based on genetic signatures. Cancer is complex! #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: Myeloma is divided into 7 subgroups based on genetic signatures. Cancer is complex! #ctsm |
| Angela Alexander PhD @thecancergeek T2. IMO a good understanding of pts tumor biology should drive trial search strategy...some examples in next few tweets #ctsm |
| Cure Forward @CureForward RT @thecancergeek: Please ask if I use any terminology and forget to define it. I forget sometimes. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. IMO a good understanding of pts tumor biology should drive trial search strategy...some examples in next few tweets #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. IMO a good understanding of pts tumor biology should drive trial search strategy...some examples in next few tweets #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @thecancergeek: T2. IMO a good understanding of pts tumor biology should drive trial search strategy...some examples in next few tweets #ctsm |
| Angela Alexander PhD @thecancergeek @MyelomaTeacher indeed. There are several different classification schemes in BC that exist. #ctsm |
 | Liz Szabo @LizSzabo RT @CureForward: We are getting a an awesome overview from @thecancergeek on #clinicaltrials behind the scenes #ctsm |
| Angela Alexander PhD @thecancergeek T2. Example: new metastatic ER+ late recurrence - looking for ways 2 max duration of time on endocrine tx. CDK4/6i +/- mTORi combos! #ctsm |
| Angela Alexander PhD @thecancergeek T2. Some useful terminology in case not clear: CDK4/6i = CDK4 and CDK6 inhibitor. mTORi = mTOR inhibitor. #ctsm |
| Dr. Kelly Shanahan @stage4kelly @thecancergeek So true but so many community oncs, where most of us are treated, don't recommend rebiopsy with progression. Need to educate patients. #ctsm |
| Cure Forward @CureForward Remember, we'ill share the link to the transcript of this chat when it's available and @storify it. It's going to be a great resource! #ctsm |
| Liz Szabo @LizSzabo RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Angela Alexander PhD @thecancergeek T2. Should say that CDKs are cyclin dependent kinases that regulate cell cycle (cell division processes). Important in many cancers #ctsm |
| The IBC Network Foundation @TalkIBC RT @thecancergeek: T2. ER/PR/HER2 status can change throughout course of disease e.g. change btwn primary & mets, & btwn mets. https://t.co/W1GeXBD49j #ctsm |
 | Stacie Dusetzina @DusetzinaS RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Cure Forward @CureForward @thecancergeek That is a lot of alphabet soup! Is there a resource patients can go to to learn more about these acronyms? #ctsm |
| Liz Szabo @LizSzabo This chat is going on now. https://t.co/HtMyyqapic |
| Cure Forward @CureForward RT @thecancergeek: T2. Should say that CDKs are cyclin dependent kinases that regulate cell cycle (cell division processes). Important in many cancers #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey Sidebar: Like cream, we rise. #patientincluded has charter for JOURNALS. Start rattling [editorial paywalled] cages! #ctsm |
 | Jon Boyle @BoyleLab RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Angela Alexander PhD @thecancergeek @CureForward not that I know of. Please just ask. Some are protein names, and we can put in context like I did for CDK. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @CureForward not that I know of. Please just ask. Some are protein names, and we can put in context like I did for CDK. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey THIS ALL DAY >>> RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Angela Alexander PhD @thecancergeek T2. For trial search for CDK4/6i look for Ibrance/Palbociclib, Ribociclib/Kisqali, or Abemaciclib. 2 mTORi - Afinitor and MLN0128 #ctsm |
| Cure Forward @CureForward @thecancergeek Thank you, Angela! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. For trial search for CDK4/6i look for Ibrance/Palbociclib, Ribociclib/Kisqali, or Abemaciclib. 2 mTORi - Afinitor and MLN0128 #ctsm |
| Angela Alexander PhD @thecancergeek T2. Targeted drugs thought 2 help AI/SERDs work better based on labwork. Qu’s being asked in trials now are best sequence & combos #ctsm |
| The IBC Network Foundation @TalkIBC also with HER 2 status can change, we need to be up on trials, and how to be in the front of the line. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Targeted drugs thought 2 help AI/SERDs work better based on labwork. Qu’s being asked in trials now are best sequence & combos #ctsm |
| Cure Forward @CureForward RT @MightyCasey: THIS ALL DAY >>> RT @MyelomaTeacher: THIS ALL DAY >>> RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Cure Forward @CureForward RT @TalkIBC: also with HER 2 status can change, we need to be up on trials, and how to be in the front of the line. #ctsm |
| Angela Alexander PhD @thecancergeek T2. AI = aromatase inhibitors (type of endocrine therapy that decreases production of estrogen). SERD = ER degrader drugs #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey +100000 >> RT @TalkIBC: also with HER 2 status can change, we need to be up on trials, and how to be in the front of the line. #ctsm |
| The IBC Network Foundation @TalkIBC RT @MightyCasey: THIS ALL DAY >>> RT @MyelomaTeacher: THIS ALL DAY >>> RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Cure Forward @CureForward @TalkIBC Please elaborate on this, Terry. #ctsm |
| Angela Alexander PhD @thecancergeek T2. Later in treatment mets ER+ becomes more like TNBC biology typically. Look for some overlapping options like ADCs/novel chemos #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Later in treatment mets ER+ becomes more like TNBC biology typically. Look for some overlapping options like ADCs/novel chemos #ctsm |
| Angela Alexander PhD @thecancergeek T2. 2nd Example: metastatic TNBC - immunotherapy trial options more abundant & more likely to work 1st-2nd line, along w/ chemo. #ctsm |
| Cure Forward @CureForward If you or someone you know has a dx of Inflammatory #BreastCancer or TNBC, you will want to learn from @thecancergeek! #bcsm #ctsm |
 | couragesings @couragesings RT @MightyCasey: Sidebar: Sidebar: Like cream, we rise. #patientincluded has charter for JOURNALS. Start rattling [editorial paywalled] cages! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. 2nd Example: T2. 2nd Example: metastatic TNBC - immunotherapy trial options more abundant & more likely to work 1st-2nd line, along w/ chemo. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. Later in treatment mets ER+ becomes more like TNBC biology typically. Look for some overlapping options like ADCs/novel chemos #ctsm |
| Angela Alexander PhD @thecancergeek T2. Hurts me to have a TNBC pt progress after every chemo & then look for trials......sadly too late 4 most exciting mid-phase trials #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. 2nd Example: T2. 2nd Example: metastatic TNBC - immunotherapy trial options more abundant & more likely to work 1st-2nd line, along w/ chemo. #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @CureForward: If you or someone you know has a dx of Inflammatory #BreastCancer or TNBC, you will want to learn from @thecancergeek! #bcsm #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Hurts me to have a TNBC pt progress after every chemo & then look for trials......sadly too late 4 most exciting mid-phase trials #ctsm |
| The IBC Network Foundation @TalkIBC @CureForward many don't know their tumor can change for a HER + to TN. miss opps for treatments. does that help? #ctsm |
| Angela Alexander PhD @thecancergeek T2. In comparison, right now HER2+ MBC trials are mainly later line, after Pertuzumab &-T-DM1. Brain mets criteria R critical 2 check #ctsm |
| Inspire @InspireIsHealth RT @CureForward: If you or someone you know has a dx of Inflammatory #BreastCancer or TNBC, you will want to learn from @thecancergeek! #bcsm #ctsm |
| The IBC Network Foundation @TalkIBC RT @thecancergeek: T2. Hurts me to have a TNBC pt progress after every chemo & then look for trials......sadly too late 4 most exciting mid-phase trials #ctsm |
| Cure Forward @CureForward @thecancergeek This is so important. Thank you for helping to spread the word about the changing world of #bcsm #precisionmedicine #ctsm |
| Cure Forward @CureForward RT @TalkIBC: @CureForward many don't know their tumor can change for a HER + to TN. miss opps for treatments. does that help? #ctsm |
| Cure Forward @CureForward @TalkIBC Yes! Thank you! #ctsm |
| Angela Alexander PhD @thecancergeek T2. Complexity arises re what 2 do if receptor discordance & what if new receptors aren’t making tumor susceptible 2 known good drugs #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. In comparison, right now HER2+ MBC trials are mainly later line, after Pertuzumab &-T-DM1. Brain mets criteria R critical 2 check #ctsm |
 | Sakinah Kaiser (She/Her) @themuslimhippie RT @CureForward: If you or someone you know has a dx of Inflammatory #BreastCancer or TNBC, you will want to learn from @thecancergeek! #bcsm #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. In comparison, right now HER2+ MBC trials are mainly later line, after Pertuzumab &-T-DM1. Brain mets criteria R critical 2 check #ctsm |
| Angela Alexander PhD @thecancergeek T2. Precision medicine barriers - so far, breast cancer genomics has not given us many new actionable targets w/ avail drugs #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. Complexity arises re what 2 do if receptor discordance & what if new receptors aren’t making tumor susceptible 2 known good drugs #ctsm |
| Cure Forward @CureForward T3 is coming up soon #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. Precision medicine barriers - so far, breast cancer genomics has not given us many new actionable targets w/ avail drugs #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Complexity arises re what 2 do if receptor discordance & what if new receptors aren’t making tumor susceptible 2 known good drugs #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Precision medicine barriers - so far, breast cancer genomics has not given us many new actionable targets w/ avail drugs #ctsm |
| Angela Alexander PhD @thecancergeek T2. Rare examples of actionable targets in BC = HER2 mutation in “HER2 normal” BCs. ESR1 mut (relative resistance to AI) #ctsm |
| Mighty #HeathenSlut Casey🇺🇦🌟 @MightyCasey RT @thecancergeek: T2. Rare examples of actionable targets in BC = HER2 mutation in “HER2 normal” BCs. ESR1 mut (relative resistance to AI) #ctsm |
| Angela Alexander PhD @thecancergeek T2. TNBCs are very heterogeneous. Top mutation = p53 (TP53) - 80% of TNBC are mutant. No direct drugs against this protein. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Rare examples of actionable targets in BC = HER2 mutation in “HER2 normal” BCs. ESR1 mut (relative resistance to AI) #ctsm |
| Angela Alexander PhD @thecancergeek T2. However it is possible that some p53 mutations may drive sensitivity to other drugs like Wee1i (AZD-1775). #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. However it is possible that some p53 mutations may drive sensitivity to other drugs like Wee1i (AZD-1775). #ctsm |
| Angela Alexander PhD @thecancergeek T2. Other overexpressed targets can be potential targets for drugs - e.g. MYC overexpression common in TNBC (75%+). #ctsm |
| Cure Forward @CureForward T3. How Might We Understand The Barriers To #ClinicalTrial Enrollment? #ctsm |
| Dr. Kelly Shanahan @stage4kelly @thecancergeek Too many trials exclude brain mets. @METUPorg wants to change this! #ctsm |
| Cure Forward @CureForward RT @stage4kelly: @thecancergeek Too many trials exclude brain mets. @METUPorg wants to change this! #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: T3. How Might We Understand The Barriers To #ClinicalTrial Enrollment? #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @thecancergeek: T2. Precision medicine barriers - so far, breast cancer genomics has not given us many new actionable targets w/ avail drugs #ctsm |
| Angela Alexander PhD @thecancergeek T2. Bromodomain inhibitors can target MYC indirectly. MYC targeting is a hot area in translational science right now. Keep an eye out! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T2. Bromodomain inhibitors can target MYC indirectly. MYC targeting is a hot area in translational science right now. Keep an eye out! #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @thecancergeek: T2. However it is possible that some p53 mutations may drive sensitivity to other drugs like Wee1i (AZD-1775). #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @thecancergeek: T2. Other overexpressed targets can be potential targets for drugs - e.g. MYC overexpression common in TNBC (75%+). #ctsm |
| Cure Forward @CureForward T3. We know there are so many barriers to #clinicaltrial enrollment - how might we understand them? #ctsm |
| Angela Alexander PhD @thecancergeek T3. @Stage4Kelly makes a good point - brain mets are a challenge re criteria. One is the natural history can be highly variable #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T3. @Stage4Kelly makes a good point - brain mets are a challenge re criteria. One is the natural history can be highly variable #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher There are lots of barriers to CT enrollment. Pts think that if their doc doesn't recommend a trial there isn't one worth considering #ctsm |
| Cure Forward @CureForward @thecancergeek @stage4kelly What does "the natural history can be highly variable" mean, Angela? #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: There are lots of barriers to CT enrollment. Pts think that if their doc doesn't recommend a trial there isn't one worth considering #ctsm |
| Angela Alexander PhD @thecancergeek T3. My thoughts on BMs are that stable/treated should be allowed, unless large amt of data on lack of BBB penetration #ctsm |
| Cure Forward @CureForward @thecancergeek We are assuming that BM = Brain Mets, and BBB = Blood Brain Barrier! #ctsm |
| Inspire @InspireIsHealth RT @MyelomaTeacher: There are lots of barriers to CT enrollment. Pts think that if their doc doesn't recommend a trial there isn't one worth considering #ctsm |
 | martha lou @marthaevapearl RT @CureForward: We are getting a an awesome overview from @thecancergeek on #clinicaltrials behind the scenes #ctsm |
| Helen Harvey @helenha00779279 RT @thecancergeek: T2. Bromodomain inhibitors can target MYC indirectly. MYC targeting is a hot area in translational science right now. Keep an eye out! #ctsm |
| Vanessa L. Merker, PhD @vlmerker T3. Even though the drugs in clinical trials usually don't cost $, there are still lots of socioeconomic barriers to joining trials #ctsm |
| Angela Alexander PhD @thecancergeek @CureForward HER2+ BMs are very different in pts than TN and ER+. HER2+ often earlier, radiation sensitive, longer pt life w/ them #ctsm |
| Cure Forward @CureForward @thecancergeek Can you tell us why brain mets are so often a reason for exclusion? #bcsm #ctsm |
| Cure Forward @CureForward RT @vlmerker: T3. Even though the drugs in clinical trials usually don't cost $, there are still lots of socioeconomic barriers to joining trials #ctsm |
| Angela PhD @AShartrand @thecancergeek As someone w mTNBC who's going to need a new treatment soon it's also frustrating to know that I can't afford any washout period #ctsm | |
| Dr. Kelly Shanahan @stage4kelly RT @thecancergeek: T2. Bromodomain inhibitors can target MYC indirectly. MYC targeting is a hot area in translational science right now. Keep an eye out! #ctsm |
| Cure Forward @CureForward @vlmerker Yes, absolutely! Location, travel/housing costs and more. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @CureForward HER2+ BMs are very different in pts than TN and ER+. HER2+ often earlier, radiation sensitive, longer pt life w/ them #ctsm |
| Angela Alexander PhD @thecancergeek @CureForward in contrast TNBC brain mets often numerous & in the presence of visceral mets, a huge challenge overall. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @CureForward in contrast TNBC brain mets often numerous & in the presence of visceral mets, a huge challenge overall. #ctsm |
 | Christina Lizaso @btrfly12 RT @MyelomaTeacher: There are lots of barriers to CT enrollment. Pts think that if their doc doesn't recommend a trial there isn't one worth considering #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Why cant't trials have three arms? BM, SOC and Non BM ?#ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @AShartrand: @thecancergeek As someone w mTNBC who's going to need a new treatment soon it's also frustrating to know that I can't afford any washout period #ctsm |
 | Shaalan Beg MD MBA FASCO @ShaalanBeg Very true. one that we see a lot in a safety net hospital is transport to and from the hospital #ctsm https://t.co/WC07hsSLQX |
| Cure Forward @CureForward RT @MyelomaTeacher: Why cant't trials have three arms? BM, SOC and Non BM ?#ctsm |
| Cure Forward @CureForward RT @ShaalanBeg: Very true. one that we see a lot in a safety net hospital is transport to and from the hospital #ctsm https://t.co/WC07hsSLQX |
| Christina Lizaso @btrfly12 RT @MightyCasey: THIS ALL DAY >>> RT @MyelomaTeacher: THIS ALL DAY >>> RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Cure Forward @CureForward @ShaalanBeg Hello, Shaalan, thank you for joining us tonight! #ctsm |
| Angela Alexander PhD @thecancergeek @CureForward Often there's little preclinical data on BBB penetration. Also side effects of large burden BMs=difficult 2 attribute SEs #ctsm |
| Christina Lizaso @btrfly12 RT @MightyCasey: Sidebar: Sidebar: Like cream, we rise. #patientincluded has charter for JOURNALS. Start rattling [editorial paywalled] cages! #ctsm |
| Vanessa L. Merker, PhD @vlmerker @TalkIBC I can 100% understand that. It costs $9-$14 to park at my hospital, depending on how long you stay. It adds up! #ctsm |
| Dr. Kelly Shanahan @stage4kelly T3. Barriers: oncs don't offer, insurances doesn't pay, not all of us live near research center, washout periods, exclusions numerous #ctsm |
| Cure Forward @CureForward This chat is going very fast! T4 will be up in a few! #ctsm |
| Cure Forward @CureForward RT @stage4kelly: T3. Barriers: T3. Barriers: oncs don't offer, insurances doesn't pay, not all of us live near research center, washout periods, exclusions numerous #ctsm |
| Hamza Khan @HamzaSKhan_ T3 - Barriers to enrollment differ between trials & sites. Imp to have a discussion around potential barriers during study start-up. #ctsm |
| Angela Alexander PhD @thecancergeek @MyelomaTeacher its a matter of statistics to have power to make conclusions without inc overall trial $ #ctsm |
| Cure Forward @CureForward @akknowles1 @vlmerker Hi April! You made it to the chat! #ctsm |
| Cure Forward @CureForward RT @CRAExpert: T3 - Barriers to enrollment differ between trials & sites. Imp to have a discussion around potential barriers during study start-up. #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher I'm learning a lot about Breast Cancer tonight. I'm sure some of that new knowledge will be transferable to #Myeloma CT #ctsm |
| Alicia C. Staley @stales RT @thecancergeek: T2. TNBCs are very heterogeneous. Top mutation = p53 (TP53) - 80% of TNBC are mutant. No direct drugs against this protein. #ctsm |
| Alicia C. Staley @stales RT @thecancergeek: T2. However it is possible that some p53 mutations may drive sensitivity to other drugs like Wee1i (AZD-1775). #ctsm |
| Alicia C. Staley @stales RT @thecancergeek: T2. Other overexpressed targets can be potential targets for drugs - e.g. MYC overexpression common in TNBC (75%+). #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @MyelomaTeacher its a matter of statistics to have power to make conclusions without inc overall trial $ #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: I'm learning a lot about Breast Cancer tonight. I'm sure some of that new knowledge will be transferable to #Myeloma CT #ctsm |
| Alicia C. Staley @stales RT @CureForward: T3. How Might We Understand The Barriers To #ClinicalTrial Enrollment? #ctsm |
| Cure Forward @CureForward T4. What Can All Stakeholders In The System Do To Overcome These Barriers? #ctsm |
| Shaalan Beg MD MBA FASCO @ShaalanBeg Bench Scientists: involve clinicians, Social media helps too, hosts tours to the lab - always a big hit #ctsm https://t.co/edTmXk3c6b |
| Christina Lizaso @btrfly12 RT @CureForward: To learn more about @thecancergeek, please see https://t.co/o84mQ0imE1 #ctsm |
| Alicia C. Staley @stales RT @thecancergeek: T2. Bromodomain inhibitors can target MYC indirectly. MYC targeting is a hot area in translational science right now. Keep an eye out! #ctsm |
| Alicia C. Staley @stales RT @CureForward: T3. We know there are so many barriers to #clinicaltrial enrollment - how might we understand them? #ctsm |
| Cure Forward @CureForward RT @ShaalanBeg: Bench Scientists: Bench Scientists: involve clinicians, Social media helps too, hosts tours to the lab - always a big hit #ctsm https://t.co/edTmXk3c6b |
| Dr. Kelly Shanahan @stage4kelly T3. Need more collab between research center and lova@onc@so some tx/monitoring can be done locally #ctsm |
| Cure Forward @CureForward RT @stage4kelly: T3. Need more collab between research center and lova@onc@so some tx/monitoring can be done locally #ctsm |
| Kelly's Heroes @1KellysHeroes T3. Not sure if this is a barrier per se, but limited offerings in trials for second-line treatment #ctsm |
| Alicia C. Staley @stales RT @MyelomaTeacher: Why cant't trials have three arms? BM, SOC and Non BM ?#ctsm |
| Angela Alexander PhD @thecancergeek T4. As a CSC I try to have our social workers meet w/ candidates to help w/ travel resources. Some free travel helps. #ctsm |
| Cure Forward @CureForward It's T4 - bring your ideas, folks! #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Patient Advocates need to share resources for clinical trials and help debunk myths associated with trials #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T4. As a CSC I try to have our social workers meet w/ candidates to help w/ travel resources. Some free travel helps. #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: Patient Advocates need to share resources for clinical trials and help debunk myths associated with trials #ctsm |
| Cure Forward @CureForward @MyelomaTeacher Yes! Our PMAs do that :) #ctsm |
| The IBC Network Foundation @TalkIBC RT @thecancergeek: T4. As a CSC I try to have our social workers meet w/ candidates to help w/ travel resources. Some free travel helps. #ctsm |
| Angela PhD @AShartrand RT @stage4kelly: T3. Barriers: T3. Barriers: oncs don't offer, insurances doesn't pay, not all of us live near research center, washout periods, exclusions numerous #ctsm | |
| Cure Forward @CureForward RT @1KellysHeroes: T3. Not sure if this is a barrier per se, but limited offerings in trials for second-line treatment #ctsm |
| Shaalan Beg MD MBA FASCO @ShaalanBeg Glad I stumbled on to #ctsm @cureforward - a topic near to my heart. |
| Angela Alexander PhD @thecancergeek T4. I see 1 role as a CSC will be to carefully vet new protocols & speak up about issues I see from pt perspective more #ctsm |
| Cure Forward @CureForward RT @ShaalanBeg: Glad I stumbled on to #ctsm @cureforward - a topic near to my heart. |
| Cure Forward @CureForward @ShaalanBeg We are so glad you did too! We hold this chat once a month! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T4. I see 1 role as a CSC will be to carefully vet new protocols & speak up about issues I see from pt perspective more #ctsm |
| Angela Alexander PhD @thecancergeek T4. Unfortunately busy PIs can overlook things if using previous protocol as a template 4 new similar ones w/o thinking thru criteria #ctsm |
| Dave Bjork @bjork5 @ShaalanBeg Patients connecting to labs 👍🏻👍🏻👍🏻 #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Having researchers share what they are doing with cancer patients helps the patients understand cancer research #ctsm |
| Hamza Khan @HamzaSKhan_ T4-Increased collab b/w sponsor, site & CRO from the start. Goal is well being of patients on the trial. We are all in this together! #ctsm |
| Cure Forward @CureForward @MyelomaTeacher Here's a link to your great post about patient resources for #clinicaltrials: https://t.co/jJzwHHPKl5 #ctsm |
| Vanessa L. Merker, PhD @vlmerker T4. Researchers can commit to #patientengagement principles, involve patients in study design/outcome selection #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T4. Unfortunately busy PIs can overlook things if using previous protocol as a template 4 new similar ones w/o thinking thru criteria #ctsm |
| Cure Forward @CureForward RT @bjork5: @ShaalanBeg Patients connecting to labs 👍🏻👍🏻👍🏻 #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: Having researchers share what they are doing with cancer patients helps the patients understand cancer research #ctsm |
| Inspire @InspireIsHealth RT @MyelomaTeacher: Having researchers share what they are doing with cancer patients helps the patients understand cancer research #ctsm |
| Cure Forward @CureForward RT @CRAExpert: T4-Increased collab b/w sponsor, site & CRO from the start. Goal is well being of patients on the trial. We are all in this together! #ctsm |
| Cure Forward @CureForward RT @vlmerker: T4. Researchers can commit to #patientengagement principles, involve patients in study design/outcome selection #ctsm |
| Dr. Kelly Shanahan @stage4kelly Oops: should be local onc!! #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @CureTalks and @MyelomaCRowd offer podcasts with #Myeloma Researchers. Patients get excited about enrolling trials. #ctsm |
| Cure Forward @CureForward Keep your suggestions coming, everyone! #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: @CureTalks and @MyelomaCRowd offer podcasts with #Myeloma Researchers. Patients get excited about enrolling trials. #ctsm |
| Cure Forward @CureForward #CTSM https://t.co/Toxcmtb3Zb |
| Cure Forward @CureForward @TalkIBC Great question, Terry! #CTSM |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher If patients are part of the clinical trial continuum from the start they will feel onwership and help with recruitment #ctsm |
| Dr. Kelly Shanahan @stage4kelly @thecancergeek My primary onc doesn't have a CSC or a social worker. Or a nurse navigator. This is the reality for many of us. #ctsm |
| Angela PhD @AShartrand @CureForward very frustrating that many trials don't post results in https://t.co/hlHbNkDwNs - if they do data isn't in a consistent #ctsm | |
| Cure Forward @CureForward RT @MyelomaTeacher: If patients are part of the clinical trial continuum from the start they will feel onwership and help with recruitment #ctsm |
| Cure Forward @CureForward RT @stage4kelly: @thecancergeek My primary onc doesn't have a CSC or a social worker. Or a nurse navigator. This is the reality for many of us. #ctsm |
| The IBC Network Foundation @TalkIBC sorry for typos. I get excited talking about this. This matters. #ctsm |
| Angela PhD @AShartrand @CureForward very frustrating that many trials don't post results in https://t.co/hlHbNkDwNs - if they do data isn't in a consistent format #ctsm | |
| Dr. Kelly Shanahan @stage4kelly RT @MyelomaTeacher: Having researchers share what they are doing with cancer patients helps the patients understand cancer research #ctsm |
| Angela Alexander PhD @thecancergeek T4. Regulatory barriers sometimes exist for CT recruiting. The IRB must approve social media posts/ads re trials. #ctsm |
| Cure Forward @CureForward @TalkIBC No worries about the typos! Just make sure to use the hashtag so we can see your great thoughts! #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @vlmerker: T4. Researchers can commit to #patientengagement principles, involve patients in study design/outcome selection #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @AShartrand @CureForward I agree - all results should be published This is made clear in Cancer Moonshot Initiative #CTSM |
| Christina Lizaso @btrfly12 RT @MyelomaTeacher: Patient Advocates need to share resources for clinical trials and help debunk myths associated with trials #ctsm |
| Cure Forward @CureForward RT @thecancergeek: T4. Regulatory barriers sometimes exist for CT recruiting. The IRB must approve social media posts/ads re trials. #ctsm |
| Cure Forward @CureForward RT @MyelomaTeacher: @AShartrand @CureForward I agree - all results should be published This is made clear in Cancer Moonshot Initiative #CTSM |
| Shaalan Beg MD MBA FASCO @ShaalanBeg RT @thecancergeek: T4. Unfortunately busy PIs can overlook things if using previous protocol as a template 4 new similar ones w/o thinking thru criteria #ctsm |
| Cure Forward @CureForward Gather your final thoughts - we have 5 miunutes left on the clock! #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: @MyelomaTeacher Here's a link to your great post about patient resources for #clinicaltrials: @MyelomaTeacher Here's a link to your great post about patient resources for #clinicaltrials: https://t.co/jJzwHHPKl5 #ctsm |
| Dave Bjork @bjork5 @CureForward @TalkIBC We need govt funding to keep young researchers #nih Don't slash @theNCI #ctsm huge problem |
| Angela Alexander PhD @thecancergeek @akknowles1 sometimes it can, but for correlative science bloodwork, a SOP must be followed & sometimes specialty supplies are needed. #ctsm |
| Cure Forward @CureForward Save the date! Next month’s chat is Wednesday 06/28/17 at 9 pm Eastern! #ctsm |
| Hamza Khan @HamzaSKhan_ T4 - Sponsor+site+CRO set a realistic expectation around enrollment from the site. And then go from there to achieve that. #ctsm |
| Cure Forward @CureForward RT @bjork5: @CureForward @TalkIBC We need govt funding to keep young researchers #nih Don't slash @theNCI #ctsm huge problem |
| Christina Lizaso @btrfly12 RT @AShartrand: @CureForward very frustrating that many trials don't post results in https://t.co/hlHbNkDwNs - if they do data isn't in a consistent format #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @akknowles1 sometimes it can, but for correlative science bloodwork, a SOP must be followed & sometimes specialty supplies are needed. #ctsm |
| Cure Forward @CureForward RT @CRAExpert: T4 - Sponsor+site+CRO set a realistic expectation around enrollment from the site. And then go from there to achieve that. #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @CureForward: Save the date! Next month’s chat is Wednesday 06/28/17 at 9 pm Eastern! #ctsm |
| Cure Forward @CureForward Thanks so much to everyone for joining tonight’s #ctsm |
| Angela PhD @AShartrand @MyelomaTeacher @CureForward at the very least a brief summary with a table of results and key outcomes of interest is essential. Publishing takes way too long.#ctsm | |
| Christina Lizaso @btrfly12 RT @CureForward: Save the date! Next month’s chat is Wednesday 06/28/17 at 9 pm Eastern! #ctsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Great Chat everyone Now its bedtime for this girl. Sweet dreams #ctsm |
| Cure Forward @CureForward We'll share the @Symplur transcript when it's available. It's going to be a keeper! #ctsm |
| Dr. Kelly Shanahan @stage4kelly @TalkIBC @CureForward But $$$$$. I will spend over 6k to attend conferences because @METUPorg is poor. Taking $ from pharma/industry is a COI for us. #ctsm |
| Cure Forward @CureForward Goodnight!! RT @MyelomaTeacher: Great Chat everyone Now its bedtime for this girl. Sweet dreams #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @MyelomaTeacher: If patients are part of the clinical trial continuum from the start they will feel onwership and help with recruitment #ctsm |
| Angela Alexander PhD @thecancergeek Did I miss any questions? Chat doesn't have to end right away if anyone is sad I missed their tweet. #ctsm |
| Cure Forward @CureForward RT @thecancergeek: Did I miss any questions? Chat doesn't have to end right away if anyone is sad I missed their tweet. #ctsm |
| Inspire @InspireIsHealth RT @CureForward: We'll share the @Symplur transcript when it's available. It's going to be a keeper! #ctsm |
| Cure Forward @CureForward Thank you so much to @thecancergeek and to everyone who joined us tonight! #ctsm |
| Helen Harvey @helenha00779279 RT @CureForward: Thank you so much to @thecancergeek and to everyone who joined us tonight! #ctsm |
| Dr. Kelly Shanahan @stage4kelly @thecancergeek @akknowles1 But this can easily be validated and what about FEDEXing the sample!! It's freaking 2017, not pony express days! #CTSM |
| Cure Forward @CureForward @thecancergeek TY for making yourself available! Cancer researchers might seem intimidating to some, but you show us the opposite! #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @AShartrand: @CureForward very frustrating that many trials don't post results in https://t.co/hlHbNkDwNs - if they do data isn't in a consistent format #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @MyelomaTeacher: @AShartrand @CureForward I agree - all results should be published This is made clear in Cancer Moonshot Initiative #CTSM |
| Cure Forward @CureForward We'll see you next month: Wednesday 06/28/17 at 9 pm Eastern for our next #ctsm |
| Dr. Kelly Shanahan @stage4kelly RT @bjork5: @CureForward @TalkIBC We need govt funding to keep young researchers #nih Don't slash @theNCI #ctsm huge problem |
| Vanessa L. Merker, PhD @vlmerker @AShartrand @MyelomaTeacher @CureForward .@PCORI is committed to publishing abstracts for patients and for clinical professionals - I'm looking forward to seeing them! #ctsm |
| The IBC Network Foundation @TalkIBC @stage4kelly @CureForward @METUPorg I get it, but I still think we need to be there. $$ doesn't flow, I know. #ctsm |
| Cure Forward @CureForward RT @AShartrand: @MyelomaTeacher @CureForward at the very least a brief summary with a table of results and key outcomes of interest is essential. Publishing takes way too long.#ctsm |
| Cure Forward @CureForward #CTSM https://t.co/ftlIiIQZR6 |
| Cure Forward @CureForward #CTSM https://t.co/k8tKNeEFr1 |
| Angela Alexander PhD @thecancergeek @akknowles1 I hear u & hard to have a satisfactory answer. Unfortunately comparison is necessary 4 FDA approval & ? risk-benefit ratio #ctsm |
| Cure Forward @CureForward And that's a wrap! Thank you to all! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @akknowles1 I hear u & hard to have a satisfactory answer. Unfortunately comparison is necessary 4 FDA approval & ? risk-benefit ratio #ctsm |
| Cure Forward @CureForward RT @TalkIBC: @stage4kelly @CureForward @METUPorg I get it, but I still think we need to be there. $$ doesn't flow, I know. #ctsm |
| Alicia C. Staley @stales RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Alicia C. Staley @stales RT @AShartrand: @CureForward very frustrating that many trials don't post results in https://t.co/hlHbNkDwNs - if they do data isn't in a consistent format #ctsm |
| Cure Forward @CureForward @zmadak @stage4kelly @TalkIBC @METUPorg Please share these great thoughts with the #CTSM tag! |
| Dr. Kelly Shanahan @stage4kelly Thank you @thecancergeek. Will we see you at ASCO17?? @catbrennan, @Majormac1 & myself will be there from @METUPorg #ctsm |
| Angela Alexander PhD @thecancergeek @MyelomaTeacher your point about layman abstracts....I wonder if advocacy orgs can facilitate & post them on their websites #ctsm |
| Cure Forward @CureForward RT @vlmerker: @AShartrand @MyelomaTeacher @CureForward .@PCORI is committed to publishing abstracts for patients and for clinical professionals - I'm looking forward to seeing them! #ctsm |
| Cure Forward @CureForward RT @stage4kelly: Thank you @thecancergeek. Will we see you at ASCO17?? @catbrennan, @Majormac1 & myself will be there from @METUPorg #ctsm |
| Alicia C. Staley @stales Great chat!!! thank you @itsthebunk you rock #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @MyelomaTeacher your point about layman abstracts....I wonder if advocacy orgs can facilitate & post them on their websites #ctsm |
| The IBC Network Foundation @TalkIBC @zmadak @stage4kelly @CureForward @METUPorg tough one, as academia is looking to advocacy now for research funding. I have a stack of requests on my desk. near 1 mill. #ctsm |
| Cure Forward @CureForward RT @stales: Great chat!!! thank you @itsthebunk you rock #ctsm |
| Angela Alexander PhD @thecancergeek @stage4kelly sadly no ASCO for me. I'll be at SABCS. Maybe next yr I can have an abstract 4 ASCO to present. #ctsm |
| Alicia C. Staley @stales @thecancergeek Thank you! i learned so much from you #ctsm |
| Vanessa L. Merker, PhD @vlmerker @AShartrand @CureForward The NIH recently changed rules about reporting - organizations will soon face hefty fines if they don't post trial results! #ctsm |
| Cure Forward @CureForward RT @stales: @thecancergeek Thank you! i learned so much from you #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @stage4kelly sadly no ASCO for me. I'll be at SABCS. Maybe next yr I can have an abstract 4 ASCO to present. #ctsm |
| Angela Alexander PhD @thecancergeek @stage4kelly was considering going to ASCO but I lost all my vacation when switched from trainee->classified staff :( #ctsm |
| Angela Alexander PhD @thecancergeek @akknowles1 they need a navigator! CureForward is going to be major help in this area I think. If only pts know to reach out! #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @stage4kelly was considering going to ASCO but I lost all my vacation when switched from trainee->classified staff :( #ctsm |
| Cure Forward @CureForward RT @thecancergeek: @akknowles1 they need a navigator! CureForward is going to be major help in this area I think. If only pts know to reach out! #ctsm |
 | Flemming Rasmussen @fgrazz RT @MightyCasey: THIS ALL DAY >>> RT @MyelomaTeacher: THIS ALL DAY >>> RT @MyelomaTeacher: I also wish that cancer researchers publish lay man abstracts #ctsm |
| Hamza Khan @HamzaSKhan_ @akknowles1 @CureForward A lot of times drug/placebo is added to be taken around the same time as SOC drugs. Low Risk if a placebo but high benefit if drug? #ctsm |
| Cure Forward @CureForward @thecancergeek @akknowles1 Yes! We're so proud of our #ClinicalTrial Navigators! They work hard 2help patients https://t.co/bIIQgCHf4W #ctsm |
| Cure Forward @CureForward RT @TalkIBC: @zmadak @stage4kelly @CureForward @METUPorg tough one, as academia is looking to advocacy now for research funding. I have a stack of requests on my desk. near 1 mill. #ctsm |
| Cure Forward @CureForward RT @vlmerker: @AShartrand @CureForward The NIH recently changed rules about reporting - organizations will soon face hefty fines if they don't post trial results! #ctsm |
| Cure Forward @CureForward @vlmerker @AShartrand This is interesting news! #ctsm |
| Cure Forward @CureForward @TalkIBC Thank you, Terry for joining us tonight! #ctsm |
| Cure Forward @CureForward RT @CRAExpert: @akknowles1 @CureForward A lot of times drug/placebo is added to be taken around the same time as SOC drugs. Low Risk if a placebo but high benefit if drug? #ctsm |
| Shaalan Beg MD MBA FASCO @ShaalanBeg @TalkIBC @bjork5 @CureForward @theNCI I have seen foundations and philanthropy make a huge impact on junior investigators #CTSM |
| Cure Forward @CureForward RT @ShaalanBeg: @TalkIBC @bjork5 @CureForward @theNCI I have seen foundations and philanthropy make a huge impact on junior investigators #CTSM |
| The IBC Network Foundation @TalkIBC @ShaalanBeg @bjork5 @CureForward @theNCI We feel we did. One jr investigator now has his now lab. We were his first large funding. #ctsm |
| The IBC Network Foundation @TalkIBC @zmadak @stage4kelly @CureForward @METUPorg true. Involve us early. #ctsm |
| The IBC Network Foundation @TalkIBC @CancerGeek @MyelomaTeacher yup. #ctsm |
| Vanessa L. Merker, PhD @vlmerker @CureForward @AShartrand A little more info on https://t.co/igOT0uQE7p reporting requirements, not sure how much it will be enforced #ctsm https://t.co/0husFQe4KQ |
#CTSM content from Twitter.